EFFICACY AND SAFETY OF PIDOTIMOD IN THE TREATMENT OF RECURRENT RESPIRATORY INFECTIONS IN CHILDREN

The immunomodulating activity of pidotimod (imunorix) was evaluated in a doublebblind, placebobcontrolled, randomized, multicentre trial, on 120 pediatric patients affected by recurrent respiratory infections. Antibiotic therapy and time of hospitalization were shorter in the patients taking pidotim...

Olles dieđut

Furkejuvvon:
Bibliográfalaš dieđut
Váldodahkkit: G. Caramia (Dahkki), E. Clemente (Dahkki), R. Solli (Dahkki), V. Mei (Dahkki), R. Cera (Dahkki), V. Carnelli (Dahkki), V. Venturoli (Dahkki), A. Corsini (Dahkki)
Materiálatiipa: Girji
Almmustuhtton: "Paediatrician" Publishers LLC, 2008-04-01T00:00:00Z.
Fáttát:
Liŋkkat:Connect to this object online.
Fáddágilkorat: Lasit fáddágilkoriid
Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!